Loading...
Rivaroxaban
India Pharmaceutical Trade Intelligence
Who Supplies Rivaroxaban to India from CANADA
India's rivaroxaban imports from CANADA total $46.0K across 43 shipments from 12 foreign suppliers. M/S. NEW LIFE MEDICALS(USA),INC leads with $9.7K in import value; the top 5 suppliers together control 71.2% of this origin. Leading Indian buyers include INDOCO REMEDIES LIMITED. This corridor reflects India's pharmaceutical import demand for rivaroxaban — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
M/S. NEW LIFE MEDICALS(USA),INC is the leading Rivaroxaban supplier from CANADA to India, with import value of $9.7K across 4 shipments. The top 5 suppliers — M/S. NEW LIFE MEDICALS(USA),INC, APOTEX INC, ADIRAMEDICA INC, AdiraMedica Inc C/o BioScript Logistics, PHARMASCIENCE INC. — collectively account for 71.2% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. NEW LIFE MEDICALS(USA),INC | $9.7K | 4 | 21.0% |
| 2 | APOTEX INC | $8.1K | 6 | 17.7% |
| 3 | ADIRAMEDICA INC | $5.7K | 4 | 12.5% |
| 4 | AdiraMedica Inc C/o BioScript Logistics | $4.8K | 1 | 10.5% |
| 5 | PHARMASCIENCE INC. | $4.4K | 4 | 9.6% |
| 6 | ADIRAMEDICA INC C O BIOSCRIPT LOGIS | $3.8K | 4 | 8.2% |
| 7 | New Life Medicals USA INC | $3.4K | 2 | 7.5% |
| 8 | MARCAN PHARMACEUTICALS INC | $3.1K | 4 | 6.8% |
| 9 | SANDOZ CANADA INC | $1.7K | 8 | 3.7% |
| 10 | AURO PHARMA INC., CANADA | $1.0K | 2 | 2.2% |
| 11 | JAMP PHARMA | $119 | 1 | 0.3% |
| 12 | Actavis Laboratories UT Inc | $35 | 3 | 0.1% |
Showing top 12 of 12 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INDOCO REMEDIES LIMITED | $13.1K | 6 | 28.5% |
| 2 | APOTEX RESEARCH PRIVATE LIMITED | $8.1K | 6 | 17.7% |
| 3 | HETERO LABS LIMITED | $5.7K | 4 | 12.5% |
| 4 | WATSON PHARMA PRIVATE LIMITED | $4.9K | 4 | 10.6% |
| 5 | BLISS GVS PHARMA LIMITED | $4.4K | 4 | 9.6% |
| 6 | WATSON PHARMA PVT LTD | $3.8K | 4 | 8.2% |
| 7 | EMCURE PHARMACEUTICALS LIMITED | $3.1K | 4 | 6.8% |
| 8 | AET LABORATORIES PRIVATE LIMITED | $1.7K | 8 | 3.7% |
| 9 | AUROBINDO PHARMA LIMITED | $1.0K | 2 | 2.2% |
| 10 | NORWICH CLINICAL SERVICES PRIVATE LIMITED | $119 | 1 | 0.3% |
Import Statistics
- Import Value
- $46.0K
- Shipments
- 43
- Foreign Suppliers
- 12
- Indian Buyers
- 10
- Avg. Shipment
- $1.1K
Other Rivaroxaban Import Origins
Related Analysis
Frequently Asked Questions — Rivaroxaban Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Rivaroxaban suppliers from CANADA to India?
The top Rivaroxaban suppliers from CANADA to India include M/S. NEW LIFE MEDICALS(USA),INC, APOTEX INC, ADIRAMEDICA INC. The leading supplier is M/S. NEW LIFE MEDICALS(USA),INC with import value of $9.7K USD across 4 shipments. India imported Rivaroxaban worth $46.0K USD from CANADA in total across 43 shipments.
QHow much Rivaroxaban does India import from CANADA?
India imported Rivaroxaban worth $46.0K USD from CANADA across 43 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Rivaroxaban from CANADA?
The main Indian buyers of Rivaroxaban sourced from CANADA include INDOCO REMEDIES LIMITED, APOTEX RESEARCH PRIVATE LIMITED, HETERO LABS LIMITED. The largest buyer is INDOCO REMEDIES LIMITED with $13.1K in imports across 6 shipments.
QWhat is the total value of Rivaroxaban imports from CANADA to India?
The total value of Rivaroxaban imports from CANADA to India is $46.0K USD, across 43 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Rivaroxaban.
- 2.Supplier/Buyer Matching: 12 foreign suppliers from CANADA and 10 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $46.0K aggregated from 43 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
43 Verified Shipments
12 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists